SHH and medulloblastoma: Based on 2021 WHO classification, medulloblastoma is categorized into four groups based on its distinct molecular subtypes, including WNT-activated, SHH-activated and TP53-wildtype, SHH-activated and TP53-mutant, and non-WNT/non-SHH (61).